Developed by MainPointe Pharmaceuticals, Nexafed is the next-generation pseudoephedrine HCl product combining effective nasal congestion relief with unique Impede® technology to significantly disrupt the conversion of pseudoephedrine to the illegal drug methamphetamine.1
The Impede® technology ingredients are safe and do not affect the efficacy of Nexafed.1
